Back

Expert endocrinologists examine growth hormone deficiency across pediatric and adult populations, covering etiology, diagnosis, treatment options including long-acting analogs, real-world registry data, transition-of-care challenges, and strategies for optimizing long-term patient outcomes across the continuum of care.

Managing Growth Hormone Deficiency Across the Continuum of Care

Episodes

Specialty:

All

Year:

All

EP. 1: Unraveling Growth Hormone Deficiency — Etiology and Prevalence

ByJoshua Yang, MD,Craig Alter, MD,Jose Garcia, MD, PhD,Nidhi Agrawal, MD

April 28th 2026

Experts compare pediatric vs adult growth hormone deficiency—causes, testing, MRI use, and why retesting matters during transition to adult care.

EP. 2: Recognizing Growth Hormone Deficiency — Symptoms, Presentation, and Quality of Life

ByJoshua Yang, MD,Craig Alter, MD,Jose Garcia, MD, PhD,Nidhi Agrawal, MD

April 28th 2026

Endocrinology experts compare pediatric and adult growth hormone deficiency—causes, testing, MRI use, and transition care tips to improve outcomes.

EP. 3: Diagnosing Growth Hormone Deficiency in Children — Testing, Tools, and Decision-Making

ByJoshua Yang, MD,Craig Alter, MD,Jose Garcia, MD, PhD,Nidhi Agrawal, MD

May 1st 2026

Learn how clinicians evaluate poor growth in kids—key labs, IGF‑1 clues, stimulation tests, and ruling out celiac, Crohn’s, thyroid issues.

EP. 4: Growth Hormone Deficiency in Adults — Presentation, Quality of Life, and Diagnostic Challenges

ByJoshua Yang, MD,Craig Alter, MD,Jose Garcia, MD, PhD,Nidhi Agrawal, MD

May 1st 2026

How pediatric endocrinologists evaluate poor growth: key labs, IGF-1/IGFBP-3, stimulation testing, and ruling out celiac, Crohn’s, thyroid disease.

EP. 5: Unmet Needs in Growth Hormone Deficiency Management

ByJoshua Yang, MD,Craig Alter, MD,Jose Garcia, MD, PhD,Nidhi Agrawal, MD

May 1st 2026

Learn key signs of pediatric growth hormone deficiency, when they appear, and why timely diagnosis boosts growth, strength, and long-term health.

EP. 6: Initiating Growth Hormone Therapy in Pediatric Patients

ByJoshua Yang, MD,Craig Alter, MD,Jose Garcia, MD, PhD,Nidhi Agrawal, MD

May 1st 2026

Experts reveal gaps in growth hormone deficiency care: better diagnostics, biomarkers, and training to improve pediatric and adult treatment access.

EP. 7: Initiating and Managing Growth Hormone Therapy in Adults

ByJoshua Yang, MD,Craig Alter, MD,Jose Garcia, MD, PhD,Nidhi Agrawal, MD

May 1st 2026

Adult growth hormone therapy starts low and titrates by IGF-1, age, and comorbidities, prioritizing quality-of-life gains and managing estrogen-related resistance.

EP. 8: Long-Acting Growth Hormone Analogs —Benefits and Safety Considerations

ByJoshua Yang, MD,Craig Alter, MD,Jose Garcia, MD, PhD,Nidhi Agrawal, MD

May 1st 2026

Clinicians tailor adult growth hormone therapy, titrating doses via IGF-1, age, estrogen effects, side effects, and prioritizing quality-of-life gains over numbers.

EP. 9: Extension Data for Long-Acting GH Analog Lonapegsomatropin in Pediatric and Adult GHD

ByJoshua Yang, MD,Craig Alter, MD,Jose Garcia, MD, PhD,Nidhi Agrawal, MD

May 1st 2026

Weekly growth hormone cuts injections—learn how it’s designed, who benefits, and key safety unknowns for cancer survivors and diabetes.

EP. 10: Extension Data for Other Long-Acting GH Analogs

ByJoshua Yang, MD,Craig Alter, MD,Jose Garcia, MD, PhD,Nidhi Agrawal, MD

May 1st 2026

Weekly lonapegsomatropin shows safe, effective growth hormone therapy, but IGF-1 may run high—learn dosing insights and adult trial outcomes.

EP. 11: Real-World Registry Data for Long-Acting GH Analogs — SkybriGHt, SkyPASS, ANSWER, and Beyond

ByJoshua Yang, MD,Craig Alter, MD,Jose Garcia, MD, PhD,Nidhi Agrawal, MD

May 1st 2026

EP. 12: Dosing Long-Acting GH Analogs — Practical Considerations for Pediatric Patients

ByJoshua Yang, MD,Craig Alter, MD,Jose Garcia, MD, PhD,Nidhi Agrawal, MD

May 1st 2026

Clinicians share practical long‑acting growth hormone dosing tips, from pen‑based rounding to IGF‑1 adjustments, plus when to continue or stop therapy in puberty.

EP. 13: Dosing and Managing Long-Acting GH Therapy in Adults — Clinical Factors, Titration, and Side Effects

ByJoshua Yang, MD,Craig Alter, MD,Jose Garcia, MD, PhD,Nidhi Agrawal, MD

May 1st 2026

Clinicians explain practical weekly growth hormone dosing—weight-based, pen-device rounding, and IGF‑1 checks—plus how puberty, fatigue, and growth velocity guide stopping therapy.

EP. 14: Transitioning GHD Patients from Pediatric to Adult Care — Challenges and Best Practices

ByJoshua Yang, MD,Craig Alter, MD,Jose Garcia, MD, PhD,Nidhi Agrawal, MD

May 1st 2026

How to keep growth hormone deficiency patients on track when moving to adult care—cutting waitlists, dropouts, and insurance delays.

EP. 15: Navigating Barriers in Adult GHD Management

ByJoshua Yang, MD,Craig Alter, MD,Jose Garcia, MD, PhD,Nidhi Agrawal, MD

May 1st 2026

Insurance barriers and missing records complicate adult growth hormone therapy, as experts urge better documentation, transition clinics, and patient-centered care to improve outcomes.

EP. 16: Growth Hormone Deficiency in Cancer Survivors

ByJoshua Yang, MD,Craig Alter, MD,Jose Garcia, MD, PhD,Nidhi Agrawal, MD

May 1st 2026

Experts debate when to start growth hormone after cancer, share pediatric vs adult wait times, and offer tips on long‑acting GH dosing.

Managing Growth Hormone Deficiency Across the Continuum of Care

Episodes

EP. 1: Unraveling Growth Hormone Deficiency — Etiology and Prevalence

EP. 2: Recognizing Growth Hormone Deficiency — Symptoms, Presentation, and Quality of Life

EP. 3: Diagnosing Growth Hormone Deficiency in Children — Testing, Tools, and Decision-Making

EP. 4: Growth Hormone Deficiency in Adults — Presentation, Quality of Life, and Diagnostic Challenges

EP. 5: Unmet Needs in Growth Hormone Deficiency Management

EP. 6: Initiating Growth Hormone Therapy in Pediatric Patients

EP. 7: Initiating and Managing Growth Hormone Therapy in Adults

EP. 8: Long-Acting Growth Hormone Analogs —Benefits and Safety Considerations

EP. 9: Extension Data for Long-Acting GH Analog Lonapegsomatropin in Pediatric and Adult GHD

EP. 10: Extension Data for Other Long-Acting GH Analogs

EP. 11: Real-World Registry Data for Long-Acting GH Analogs — SkybriGHt, SkyPASS, ANSWER, and Beyond

EP. 12: Dosing Long-Acting GH Analogs — Practical Considerations for Pediatric Patients

EP. 13: Dosing and Managing Long-Acting GH Therapy in Adults — Clinical Factors, Titration, and Side Effects

EP. 14: Transitioning GHD Patients from Pediatric to Adult Care — Challenges and Best Practices

EP. 15: Navigating Barriers in Adult GHD Management

EP. 16: Growth Hormone Deficiency in Cancer Survivors

Trending on HCPLive

Combination Therapy, Adherence, and Access: A PAH Expert Roundtable

Allergists Debate Newer Nonsteroidal Topicals for Atopic Dermatitis

CaRi-Heart Receives FDA De Novo Authorization for Coronary Inflammation

Ritlecitinib Improves Repigmentation in Nonsegmental Vitiligo Phase 3 Data

Why Allergists Aren't Prescribing New Topical Eczema Drugs